Home / Community / News / News

News

08/07/2017 - 10:53am

Although fatigue represents a substantial burden in DM1, tools must be validated to assess its diverse contributing factors in order to develop clinical trial endpoints and effective therapies.

07/06/2017 - 3:22pm

MDF staff recently attended the 2017 BIO International Convention hosted by the Biotechnology Innovation Organization (BIO). BIO offers a partnering track to patient advocacy groups, enabling meetings with companies having potentially mutual interests.

07/06/2017 - 3:11pm

Preclinical animal efficacy data used to support the scientific rational for Ionis’ phase 1/2 clinical trial in DM1 was just published.

07/06/2017 - 3:02pm

New fly models show a DM2 phenotype at least as severe as DM1 and may provide a platform for studies of genetic modifiers and candidate therapy screening in DM.

07/06/2017 - 2:53pm

A large retrospective study helps clarify genotype-cardiac phenotype relationships in adult DM1.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.